Landscapes / Targets
TP53
9 drugs act on TP53, in 9 active trials · Any stage · updated 20 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs9
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Bruton's tyrosine kinase inhibitor |
Merck & Co. · Public MRK |
Phase 3 | 19 May 2027Phase 3 trial completes | ||
| How it works | Blocks BTK | ||||
| Next date | 19 May 2027 · Phase 3 trial completes | ||||
| Also tested for | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | ||||
| Open drug page | |||||
PD-1 antibody |
Merck & Co. · Public MRK |
Phase 1/2 | 15 Dec 2026soonPhase 1/2 trial completes | ||
| Next date | 15 Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Advanced Malignant Neoplasm and 28 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 15 Dec 2026soonPhase 1/2 trial completes | |||
| Next date | 15 Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Advanced Malignant Neoplasm and 29 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jan 2027Phase 1/2 trial completes | |||
| Next date | Jan 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2028Phase 1/2 trial completes | |||
| Next date | Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Dec 2029Phase 1/2 trial completes | |||
| Next date | 30 Dec 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Oct 2032Phase 1/2 trial completes | |||
| Next date | 31 Oct 2032 · Phase 1/2 trial completes | ||||
| Also tested for | Ovarian Cancer, Small Cell Lung Cancer and 8 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Phase 1 | 31 Jul 2029Phase 1 trial completes | ||
| Next date | 31 Jul 2029 · Phase 1 trial completes | ||||
| Also tested for | Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and 6 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 9 of 9 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 · openFDA updated 20 Nov 2026